Speed is everything. A single day of untreated cerebral edema can cause permanent damage. We answer three questions within hours—not days:
The gold standard. Reveals the number, size, and exact location of metastases; distinguishes them from stroke, infection, or radiation necrosis.
identifies the source of metastases and maps systemic disease activity—guiding whether the priority is brain-first or body-first.
analyzes actionable mutations that determine blood-brain barrier-penetrant targeted therapy (e.g., osimertinib for EGFR-mutant lung cancer, lapatinib-capecitabine for HER2+ breast cancer).
